PrEP is indicated for HIV-negative individuals at risk of HIV exposure through sex or injection drug use. Oral PrEP is up to 99% effective at preventing HIV acquisition from sex and at least 74% effective from injection drug use.
The next time one of your patients needs a prescription filled for PrEP, we hope you will select an option that will save your patient money and support their adherence to their medication regimen. Our members may be eligible for a zero-dollar copay. See our flyer for zero-dollar copay criteria and a comparison of the FDA-approved oral treatment options for PrEP: Descovy® and Truvada®.
